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Abstract
Crucial information about the practice of
healthcare is recorded only in free-form text,
which creates an enormous opportunity for
high-impact NLP. However, annotated health-
care datasets tend to be small and expensive
to obtain, which raises the question of how to
make maximally efficient uses of the available
data. To this end, we develop an LSTM-CRF
model for combining unsupervised word rep-
resentations and hand-built feature representa-
tions derived from publicly available health-
care ontologies. We show that this com-
bined model yields superior performance on
five datasets of diverse kinds of healthcare text
(clinical, social, scientific, commercial). Each
involves the labeling of complex, multi-word
spans that pick out different healthcare con-
cepts. We also introduce a new labeled dataset
for identifying the treatment relations between
drugs and diseases.
1 Introduction
The healthcare system generates enormous quanti-
ties of data, but its tools for analytics and decision-
making rely overwhelmingly on a narrow subset of
structured fields, especially billing codes for pro-
cedures, diagnoses, and tests. The textual fields
in medical records are generally under-utilized or
completely ignored. However, these clinical texts
are our only consistent source of information on a
wide variety of crucial factors – hypotheses con-
sidered and rejected, treatment rationales, obsta-
cles to care, brand recognition, descriptions of un-
certainty, social and lifestyle factors, and so forth.
Such information is essential to gaining an accu-
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Figure 1: Model diagram. In our full model, words are
represented by pretrained ELMo embeddings, which
feed into LSTM cells, and by sparse ontology-derived
feature representations, which are fed to a dense layer
with dropout to produce a lower-dimensional represen-
tation that is concatenated with the hidden states of the
LSTM. The resulting mixed feature representation is
fed into a CRF layer that forms the basis for token-level
label predictions. We assess this full model against
variants without the LSTM or hand-built features to
motivate the full version.
rate picture of the healthcare system and the ex-
periences of individual patients, creating an enor-
mous opportunity for high-impact NLP.
However, annotated clinical text datasets are
scarce and tend to be small, for two reasons. First,
data access is usually highly limited because of
privacy considerations; the inherent richness of
language data means that de-identification is hard
or impossible (Uzuner et al., 2007). Second, be-
cause healthcare concepts are complex, the needed
annotations generally must be provided by domain
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specialists who are trained both in the practice of
healthcare and in the interpretation of healthcare
records. Such experts are in high demand, and the
annotation work they do is intellectually challeng-
ing, so the annotated datasets they produce are, by
any measure, very expensive. The result is that
even the largest annotated clinical text datasets are
small by comparison with those from other areas
of NLP, and this has profound consequences for
the kinds of models that are viable in this space.
In this paper, we define a hybrid LSTM-CRF
model that is effective for real-world clinical text
datasets. The architecture is sketched in fig-
ure 1. Its crucial property is that it synthesizes
two kinds of feature representation: dense repre-
sentations that can be trained on any large text
corpus (not necessarily using clinical text) and
sparse, high-dimensional feature representations
based on hand-built feature functions. Hand-built
feature functions are especially powerful in health-
care because they can leverage the numerous high-
quality medical lexicons and ontologies that are
publicly available. As a result, such features can
achieve impressive coverage with relatively little
additional effort.
We show that this combined model yields supe-
rior performance on five datasets of diverse kinds
of healthcare text: two clinical, one social me-
dia, one scientific, and one commercial/regulatory
(official drug labels). Each task involves the la-
beling of complex, multi-word spans that pick
out diverse healthcare concepts: the Chemical–
Disease Relation dataset (CDR; Wei et al. 2015);
the Penn Adverse Drug Reaction Twitter dataset
(ADR; Nikfarjam et al. 2015); a new disease diag-
nosis dataset; a new prescription reasons dataset
that involves identifying complex REASON spans
for drug–prescription actions; and a new dataset of
10K drug–disease treatment descriptions, which
we release with this paper.
2 Models
Our full model is depicted schematically in fig-
ure 1. Its modular structure defines a number of
variations that allow us to quantify the value of in-
cluding dense and sparse feature representations
obtained from diverse sources.
Individual words are represented in two ways
in the full model: with dense, pretrained vectors
and with sparse, high-dimensional feature repre-
sentations derived from hand-built feature func-
tions. If the dense representations are removed,
the LSTM cells are also removed, resulting in a
standard CRF (Lafferty et al., 2001; Sutton and
McCallum, 2011). If the sparse representations
are removed, the result is a standard LSTM-based
RNN (Hochreiter and Schmidhuber, 1997).
We explore two ways of initializing the dense
representations: random initialization according
to the method of Glorot and Bengio (2010) and
the ELMo embeddings released by Peters et al.
(2018). The ELMo embeddings were trained on
the 1 billion word benchmark of Chelba et al.
(2013) – general newswire text not specialized to
the healthcare space. What is special about ELMo
embeddings, as compared to more standard word
representation learning, is that they are obtained
from the parameters of a full language model, so
that each word’s representation varies by, and is
sensitive to, its linguistic context; see also Mc-
Cann et al. 2017; Radford et al. 2018.
The nature of the hand-built feature representa-
tions varies by task, so we leave most of the details
to section 3. All the models featurize each word
in part using the word and part-of-speech tag of
the current word and the preceding and following
four words. They also include features that seek
to characterize the nature of the semantic envi-
ronment: markers of negation, uncertainty, hedg-
ing, and other core task-specific contextual cues.
Finally, the feature functions make extensive use
of drug and disease lexicons to identify the types
of words. The drug lexicons are RxNorm, the
National Drug Code (NDC), FDA Drug Labels,
FDA Orange Book, and the OpenFDA fields found
in a number of public FDA datasets (e.g., Drug
Adverse Events). The disease lexicons are de-
rived from historical ICD-9 and ICD-10 code sets,
SNOMED-CT (Spackman et al., 1997), the Dis-
ease Ontology (Schriml et al., 2011; Kibbe et al.,
2014), and the Wikidata graph (Vrandecˇic´ and
Kro¨tzsch, 2014). The wealth and diversity of these
sources is typical of healthcare and highlights the
potential for taking advantage of such resources
to help overcome the challenges of small datasets.
Table A1 shows an example of hand-built features.
In the full model, we include a dense layer that
transforms the sparse feature representations, and
we apply dropout (Hinton et al., 2012) to this
layer. These transformed representations are con-
catenated with the hidden states of the LSTM to
produce the full representations for each word.
Dataset Example
Diagnosis Detection Asymptomatic/POSITIVE bacteriuria/POSITIVE , could be
neurogenic/CONCERN bladder/CONCERN disorder/CONCERN .
Prescription Reasons I will go ahead and place him on Clarinex/PRESCRIBED for/REASON
his/REASON seasonal/REASON allergic/REASON rhinitis/REASON .
Penn Adverse Drug
Reactions (ADR)
#TwoThingsThatDontMixWell venlafaxine and alcohol- you’ll cry/ADR
and throw/ADR chairs/ADR at your mom’s BBQ.
Chemical–Disease
Relations (CDR)
Ocular/DISEASE and/DISEASE auditory/DISEASE toxicity/DISEASE in
hemodialyzed patients receiving desferrioxamine/DRUG .
Drug–Disease
Relations
Indicated for the management of active/TREATS rheumatoid/TREATS
arthritis/TREATS and should not be used for rheumatoid/CONTRA
arthritis/CONTRA in/CONTRA pregnant/CONTRA women/CONTRA .
Table 1: Short illustrative examples from each of our five datasets, with some modifications for reasons of space.
CDR examples are typically much longer, encompassing an entire scientific title and abstract. Section 3 more fully
explicates the labels. All unlabeled tokens are labeled with OTHER.
Where the hand-built representations are left out,
the word representations are simply the hidden
states of the RNN; where the dense representations
are left out, the word representations are simply
the sparse representations, resulting in a standard
linear-chain CRF.
There is a natural variant of the model depicted
in figure 1 in which the CRF layer is replaced by a
softmax layer. In our experiments, this was always
strictly worse than the CRF layer. Another variant
feeds the compressed hand-built features together
with ELMo embeddings into the LSTM. This too
led to inferior or comparable performance. Fi-
nally, we evaluated a version that used a bidirec-
tional LSTM, but found that it did not yield im-
provements. Therefore, we do not include those
experimental results, to simplify the discussion.
3 Experiments
We report experiments on five different datasets:
two from transcribed clinical narratives, one from
social media, one from scientific publications, and
one from official FDA Drug Labels texts. For
each, the task is to label spans of text that identify
particular healthcare concepts. We are particularly
interested in the capacity of our models to identify
multi-word expressions in a way that is sensitive to
the semantics of the environment – for example, to
distinguish between a drug prescribed and a drug
discontinued, or to distinguish disease mentions as
diagnoses, diagnostic concerns, or ruled-out diag-
noses. Table 1 gives a short illustrative example
from each dataset. Table A2 gives detailed statis-
tics for each dataset.
Three of the datasets are already partitioned into
training and test sets. For these, we tune the hy-
perparameters using 5-fold cross-validation on the
training set, train the model with tuned hyperpa-
rameters on the training set, and then evaluate the
performance of the trained model on the test set.
The other two datasets do not have predefined
splits. For these, we divide them equally into
five parts. For each fold, the hyperparameters
are tuned on the training data (also using 5-fold
cross-validation), and the best model is then ap-
plied to the test data for the evaluation. These ex-
periments are repeated three times to smooth out
variation deriving from the random initialization
of the model parameters, though we use the hyper-
parameters selected for each fold in the first run in
the subsequent two experiments to save computa-
tional resources.
We use the Adam optimizer (Kingma and Ba,
2014), with β1 = 0.9 and β2 = 0.999, the train-
ing batch size set to 16, and the dropout rate set
to 0.5 for all the experiments. The step size η and
the coefficients of the `1 and `2 regularizers c1 and
c2 are tuned. The step size is first tuned by setting
both c1 = c2 = 0, and then c1 and c2 are tuned us-
ing random search (Bergstra and Bengio, 2012) for
ten settings. Table A3 provides additional details
on our hyperparameters and evaluation protocol.
The source code for our experiments and models
is available.1
3.1 Diagnosis Detection
Our Diagnosis Detection dataset is drawn from a
larger collection clinical narratives – de-identified
transcriptions of the reports healthcare profession-
als record about their interactions with patients.
The corpus was provided to us by a healthcare
start-up. We sampled and labeled 6,042 sen-
tences for information about disease diagnoses.
The labels are POSITIVE DIAGNOSIS, CONCERN,
RULED-OUT, and OTHER. The labeling was done
by a team of domain experts. The challenging as-
pects of this task are capturing the complex, multi-
word disease names and distinguishing the seman-
tic sense of those mentions (as summarized by our
label set) based on their sentential context.
For the hand-built parts of our representations,
we extend the basic feature set described in sec-
tion 2 with cue words that help identify whether
a description is about a patient’s history or cur-
rent condition, as well as cue words for causal lan-
guage, measurements, and dates. The power these
features bring to the model, beyond what is cap-
tured in the ELMo-LSTM representations, is evi-
dent in table 2, column 1.
3.2 Prescription Reasons
Our Prescription Reasons dataset is drawn from
the same corpus of clinical narratives as our Dis-
ease Diagnosis dataset and was annotated by the
same team of domain experts. This dataset con-
tains 5,179 sentences, with labels PRESCRIBED,
DISCONTINUED, REASON, and OTHER. For the
first two labels, the majority are unigrams naming
drugs. Of special interest is the REASON category,
which captures long, highly diverse reasons for ac-
tions taken concerning prescription drugs. (The
relations are captured with additional edge annota-
tions connecting spans, but we do not model them
in this paper.) This information about the rationale
for prescription decisions is the sort of thing that
appears only in text, and it has clear value when
it comes to understanding these decisions, making
this an especially interesting task.
Our hand-built feature representations are simi-
lar to those used for Diagnosis Detection, but they
additionally contain features based in large drug
1https://github.com/roamanalytics/
roamresearch/tree/master/Papers/
Feature4Healthcare
lexicons, as discussed in section 2, as well as fea-
tures based on cue-words for different prescription
actions: switching, discontinuing, increasing, de-
creasing, and so forth. The results in table 2, col-
umn 2, clearly favor the combined model that uses
both these features and the ELMo-LSTM.
3.3 Penn Adverse Drug Reactions (ADR)
The Penn Adverse Drug Reactions (ADR; Nikfar-
jam et al. 2015) dataset is an annotated collection
of tweets giving informal adverse reactions to pre-
scription drugs. It’s thus a different kind of clinical
text than in our two previous experiments – public
self-reports by patients, rather than private techni-
cal descriptions by healthcare professionals.
The original dataset contained 1,340 labeled
tweets for training and 444 for testing. However,
due to restrictions on redistributing Twitter data,
the project team was unable to release the tweets,
but rather only a script for downloading them. Due
to tweet deletions, we were able to download only
749 train examples and 272 test examples. This
limits our ability to compare against prior work on
this dataset, but the small size further tests our hy-
pothesis that our combined model can get traction
with relatively few examples.
For our hand-built feature functions, we fol-
low the protocol specified in the ADRMine CRF
package released by Nikfarjam et al. (2015).
Key components include tokenization (Gimpel
et al., 2011), spelling correction (Cutting, 1999;
Atkinson, 2018), lemmatization, and featurization
(Loper and Bird, 2002). Thus our combined model
is a strict extension of this publicly available pack-
age (setting aside differences related to implemen-
tation and optimization). We follow Nikfarjam
et al. (2015) in using Inside/Outside/Beginning
(IOB; Ramshaw and Marcus 1995) tags.
Our test-set results, given in table 2, column 3,
show the power of our combined model. For con-
text, the best results reported by Nikfarjam et al.
are 72.1, for a CRF that includes hand-built fea-
tures as well as features based on the cluster in-
dices of distributional word representations. That
is, their model draws on similar insights to our
own. Though we only have half of the training
samples, our unified model is still able to get trac-
tion on this dataset.
3.4 Chemical–Disease Relations (CDR)
The Biocreative V Chemical Disease Relation
dataset of Wei et al. (2015) captures relationships
Diagnosis Prescription Penn Adverse Drug Chemical–Disease Drug–Disease
Detection Reasons Reactions (ADR) Relations (CDR) Relations
rand-LSTM-CRF 77.3 ± 0.05 69.6 ± 0.25 53.8 ± 0.88 85.1 ± 0.10 48.2 ± 1.12
HB-CRF 82.0 ± 0.05 78.5 ± 0.01 58.8 ± 0.12 86.2 ± 0.02 42.3 ± 0.30
ELMo-LSTM-CRF 83.9 ± 0.35 81.0 ± 0.20 65.7 ± 0.35 88.2 ± 0.34 50.6 ± 0.64
ELMo-LSTM-CRF-HB 85.3 ± 0.24∗∗∗ 82.0 ± 0.03∗∗∗ 68.5 ± 1.67∗ 89.9 ± 0.12∗∗∗ 51.9 ± 0.52∗∗
Table 2: Per-token macro-F1 scores. For ADR, the F1 scores are for chunks via approximate matching (Nikfarjam
et al., 2015; Tsai et al., 2006). ‘rand-LSTM’ is an LSTM with randomly initialized word vectors. ‘ELMo-LSTM’
is an LSTM initialized with pretrained ELMo embeddings. ‘HB’ signals sparse, high-dimensional feature repre-
sentations based on hand-built feature functions. The mean values and standard deviations are calculated using F1
scores of three runs of repeated experiments, as discussed in section 3. Statistical significance notation for the last
two rows (two top-performing models) is ∗: p < 0.05; ∗∗: p < 0.01; ∗∗∗: p < 0.001.
between chemicals and diseases in the titles and
abstracts for scientific publications. It contains
1,000 training texts and 500 test texts. Its la-
bels are CHEMICAL, DISEASE, and OTHER. This
dataset is not only from a different domain than
our others, but it also involves much longer texts.
Our hand-built feature function is exactly the
one used for the Prescription Reasons experi-
ments. We report results for the standard test set.
The power of the combined model is again evident
in the results in table 2, column 4.
3.5 Drug–Disease Relations
Our final experiments are on a new annotated
dataset that we will be releasing along with this
paper.2 The underlying corpus is FDA Drug La-
bels, which contains all the official labels for all
drugs licensed for sale in the U.S. These labels in-
clude a wide range of information, including ac-
tive ingredients, warnings, and approved usages.
Our annotation project focused on capturing the
relationship between these drugs and mentioned
diseases. The resulting labels are TREATS, PRE-
VENTS, UNRELATED and CONTRAINDICATED-
FOR. Figure A1 describes the corpus-building pro-
cess in more detail.
Since FDA Drug Labels is a public dataset, we
used this as an opportunity to see whether we
could obtain good labels via crowdsourcing. This
effort proceeded in two phases. In the first, annota-
tors identified disease spans, working from an an-
notation manual that provided guidance on how to
delimit such phrases and lexical resources to help
them identify diseases. In the second phase, anno-
tators assigned the span labels from our label set,
again using an annotation manual we created to
2https://github.com/roamanalytics/
roamresearch/tree/master/BlogPosts/
Features_for_healthcare
guide their choices.
We launched our task on Figure Eight with
10,000 sentences. It was completed within a few
days. The job was done by 1,771 people from
72 countries, the majority from Venezuela. No
special qualifications were imposed. To infer a
label for each example, we applied Expectation
Maximization (EM), essentially as in Dawid and
Skene (1979). The inter-annotator agreement be-
tween these labels and those we inferred via EM
is 0.83 for both tasks. For assessment, a team of
experts independently labeled 500 examples from
the same pool of sentences, using the same criteria
and annotation manuals as the crowdworkers. The
inter-annotator agreement between the labels in-
ferred from the crowd and those from the experts is
0.82, suggesting that the inferred labels are good.
We expect the crowdsourced labels to be used
only for training. Our test set consists entirely
of non-train examples with labels assigned by ex-
perts. This allows us to train on noisy labels, to
check for robustness, while still assessing on truly
gold labels. Our results for this experiment are
given in table 2, column 5, and point to the su-
periority of our combined model.
4 Discussion
Our discussion seeks to show that the combined
model, which shows superior performance in all
tasks (table 2), is making meaningful use of both
kinds of features (hand-built and ELMo) and both
of the major model components (LSTM and CRF).
4.1 The Role of Text Length
We expect the LSTM to handle short texts very ef-
fectively, but that its performance will be degraded
for long ones. In contrast, the CRF might fall short
of the LSTM on short texts, but it should be more
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Figure 2: Text-length experiments. Along with the distribution of text lengths, per-token macro-F1 scores of words
that fall into specific bins in the sentences are shown. For the top two datasets, the ELMo-LSTM-CRF is better at
earlier positions, while the HB-CRF is better at later ones. For the bottom two datasets, the ELMo-LSTM-CRF is
always better than the HB-CRF. In all these cases, the combined model takes advantage of both models and always
outperforms the base models. ADR dataset results are given in figure A2 due to space limitations.
robust on long ones. We thus hypothesize that the
combined model will learn to take advantage of
these comparative strengths.
We find strong support for this hypothesis in our
data. Figure 2 illustrates this. These plots track the
macro-F1 scores (y-axes) of tokens in specific lin-
ear positions (x-axes). There are two major trends.
First, in the Prescription Reasons and CDR
datasets (top two panels), we see that the HB-CRF
starts to outperform the ELMo-LSTM-CRF af-
ter about word 40 in Prescription Reasons (which
contains many long texts that list patient history;
section 3.3) and after about word 160 in CDR
(which has paragraph-length texts; section 3.4).
Second, in the Diagnosis Detection and Drug–
Disease Relations datasets (bottom two panels in
figure 2), the ELMo-LSTM-CRF model outper-
forms the HB-CRF at all positions. However, there
is still evidence that our full model is leveraging
the strengths of both of its major components, as
it outperforms both in all positions.
In summary, the performance curve of the com-
bined model is roughly an upper envelope of the
two base-model curves. The combined model is
able to achieve better performance for both short
and long texts, and for words in any position, by
utilizing features from both base models.
4.2 Analysis of the CRF Potential Scores
The potential scores (also referred to as “unary
scores” or “emissions” in some work) of the CRF
provide another method for model introspection.
These scores are the direct inputs to the final CRF
layer, where the token-level label predictions are
determined. When the potential score for a spe-
cific label is high, the CRF assigns a high weight
to that label under the contraints of adjacent la-
bels. Thus, by checking the potential scores for
the feature dimensions deriving from each of our
base models, we can gain insights into the relative
importance of these models and how the combined
model leverages features from both.
The potential scores of each word in the test set
are shown in figure 3, where the left panels show
the LSTM features and the right panels show the
CRF (hand-built) features. Due to the general ef-
fectiveness of the ELMo-LSTM, we always have
higher average potential scores from those fea-
tures. This is reflected in the mean scores at left
and in the comparatively large amount of white
(high scores) in the panels. However, the hand-
built features always make substantial contribu-
tions, especially in Diagnosis Detection, Prescrip-
tion Reasons, and CDR. We note also that, where
the performance of the two base models is very
similar (table 2), the potential scores in the com-
bined model are also more similar.
4.3 Major Improvements in Minor
Categories
One of our central motivations for this work is that
clinical datasets tend to be small due to the chal-
lenges of getting quality labels on quality data.
These size limitations impact model performance,
and the hardest hit categories tend to be the small-
est ones. Unfortunately, these are often the most
important categories, identifying rare but signif-
icant events. We are thus especially interested
in whether our combined model can address this
problem.
Table 3 suggests that the combined model does
make progress here, in that the largest gains,
across all relevant datasets, tend to be for the
smallest categories. This is very dramatically
true for the Drug–Disease Relations dataset, where
only the combined model is able to get any trac-
tion on the smallest categories; it achieves 103.5%
and 71.3% improvements in F1 score over the HB-
CRF model for the two smallest categories. It
seems clear that, in transferring compact embed-
ding representations learned from other large text
datasets, the combined model can elevate perfor-
mance on small categories to an acceptable level.
5 Prior Work
5.1 Clinical Text Labeling
Apache cTAKEs (Savova et al., 2010) extracts in-
formation from clinical text. Its labeling module
implements a dictionary look-up of concepts in the
UMLS database, and the concept is then mapped
into different semantic types (labels). Similar ex-
tractions play a role in our hand-built features, but
only as signals that our models learn to weight
against each other to make decisions.
ADRMine (Nikfarjam et al., 2015) is closer to
our own approach; it focuses on extracting ad-
verse drug reaction mentions from noisy tweets. It
combines hand-built features and word embedding
cluster features for label prediction. However, our
model is more powerful in the sense that we di-
rectly utilize the word embeddings and feed them
into the LSTM.
Habibi et al. (2017) use a combined LSTM-
CRF to achieve better NER results on 33 biomed-
ical datasets than both available NER tools and
entity-agnostic CRF methods, though they do not
incorporate hand-built features.
There are also competitions related to labeling
tasks in the context of clinical text. The i2b2 Chal-
lenge (Sun et al., 2013) includes event detection
as one of the task tracks, which is basically a la-
beling task. The best results on this task came
from a team using a simple CRF. The Biocre-
ative V Chemical–Disease relation (CDR) com-
petition (Wei et al., 2015) released a widely used
dataset for researchers to evaluate their NER tools
for biomedical text, and Verga et al. (2018) report
state-of-the-art results for a self-attention encoder,
using a dataset that extends CDR.
5.2 Efficient Annotation
Obtaining accurate annotations is expensive and
time consuming in many domains, and a rich line
of research seeks to ease this annotation burden.
Ratner et al. (2016) and Hancock et al. (2018)
propose to synthesize noisy labeling functions to
infer gold training labels, and thus make better
use of annotators’ time, by allowing them to fo-
cus on writing high-level feature functions (and
perhaps label individual examples only for evalua-
tion). These efforts are potentially complementary
to our own, and our experiments on our new Drug–
Disease dataset (section 3.5) suggest that our com-
bined model is especially robust to learning from
noisy labels compared with base models.
5.3 Related Models
A large body of work explores combined LSTM
and CRF models for text labeling. Huang et al.
(2015) use an LSTM-CRF for sequence tagging,
and Ma and Hovy (2016) propose a bi-directional
LSTM-CNNs-CRF for the same task. In addition
to word embeddings, Lample et al. (2016) utilize
character embedding information as the input to a
LSTM-CRF. Jagannatha and Yu (2016) integrate
pairwise potentials into the LSTM-CRF model,
which improves sequence-labeling performance in
clinical text. Wang et al. (2018) and Crichton et al.
(2017) use multi-task learning based on the ba-
Figure 3: Potential score experiments. Potential scores from the ELMo-LSTM and HB modules of all five datasets
are shown. Mean potential scores of both features are calibrated in the left colorbar. Higher potential scores (lighter
cells) indicate greater importance for the feature. In all five datasets, the combined model pays more attention to
the ELMo-LSTM features, but the hand-built features always contribute. Comparing with the results in table 2, we
note that when the performance of two base models is comparable, their potential scores in the combined model
are also closer.
Diagnosis Detection Prescription Reasons
Label Support F1 score Improvement Label Support F1 score Improvement
OTHER 74888 95.3 1.4% OTHER 83618 95.8 0.9%
POSITIVE 24489 86.1 4.4% REASON 9114 64.7 8.6%
RULED-OUT 2797 86.4 3.6% PRESCRIBED 5967 84.7 4.4%
CONCERN 2780 72.1 5.6% DISCONTINUED 2754 82.7 5.6%
Chemical–Disease Relations (CDR) Drug–Disease Relations
Label Support F1 score Improvement Label Support F1 score Improvement
OTHER 104530 98.3 0.5% OTHER 10634 90.8 2.3%
DISEASE 6887 84.2 6.3% TREATS 3671 76.0 5.7%
CHEMICAL 6270 87.0 6.7% UNRELATED 1145 53.8 71.3%
PREVENTS 320 41.1 103.5%
CONTRAINDICATED-FOR 69 0 –
Table 3: Relative F1 score improvements of different labels. For each label, we give the number of supporting
examples (Support), the F1 score of our combined model, and the relative improvements over the HB-CRF model.
The F1 scores of minor labels suffer from insufficient training data, and thus have lower values. However, the
combined model shows the largest relative improvements in these categories. ADR results are shown in table A4.
sic LSTM-CRF structure to improve NER perfor-
mance in biomedical text. Our model provides
an effective method for fully utilizing the sparse
ontology-driven features left out of by the above
work, which are complementary to dense embed-
dings and therefore boost performance of clinical
concept extraction with limited training data (sec-
tion 4).
There are also a number of models that mix
dense and sparse feature representations. Gorm-
ley et al. (2015) and Cheng et al. (2016) combine
both unlexicalized hand-crafted features and word
embeddings to improve the performance of rela-
tion extraction in recommender systems. How-
ever, they focus on simple multi-layer perceptron
models, rather than considering a more expressive
LSTM structure. Similarly, Wang et al. (2019) uti-
lize both sparse UMLS features and unpretrained
word embeddings as the input to an LSTM for ge-
netic association inferences from medical litera-
ture. While their UMLS features are a single look-
up table of semantic types, our model relies on
much richer resources of medical knowledge and
includes more heterogeneous and expressive hand-
built features that capture the semantic, morpho-
logical and contextual information of words (sec-
tion 2).
6 Conclusion
Clinical text datasets are expensive to label and
thus tend to be small, but the questions they can
answer are often very high-impact. It is thus in-
cumbent upon us to make maximally efficient use
of these resources. One way to do this is to draw
heavily on lexicons and other structured resources
to write feature functions. Another way is to lever-
age unlabeled data to create dense feature vectors.
The guiding hypothesis of this paper is that the
best models will make use of both kinds of infor-
mation. To explore this hypothesis, we defined a
new LSTM-CRF architecture that brings together
these two kinds of feature, and we showed that
this combined model yields superior performance
on five very different healthcare-related tasks. We
also used a variety of introspection techniques
to gain an understanding of how the combined
model balances its different sources of informa-
tion. These analyses show that the combined
model learns to pay attention to the most reliable
sources of information for particular contexts, and
that it is most effective, as compared to its simpler
variants, on smaller categories, which are often the
most crucial and the hardest to generalize about.
We also introduced the publicly available Drug–
Disease Relations dataset, which contains a large
training set of crowdsourced labels and a smaller
test set of gold labels assigned by experts. This
dataset can be used to learn facts about drug–
disease relationships that have medical signifi-
cance, and it shows that combined models like
ours can learn effectively in noisy settings.
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Sentence Hand-built features of word bacteria
antiseptic
handwash
to
decrease
bacteria
on
the
skin
.
Adjacent words features:
word-4:antiseptic, word-3:handwash, word-2:to, word-1:decrease,
word:bacteria, word+1:on, word+2:the, word+3:skin, word+4:..
Adjacent POS tags features:
tag-4:JJ, tag-3:NN, tag-2:TO, tag-1:VB,
tag:NNS, tag+1:IN, tag+2:DT, tag+3:NN, tag+4:..
Semantic environment features:
bias:1, is upper:0, is title:0, is punctuation:0,
in left context of negative cues:0, in right context of negative cues:0,
in left context of prevents cues:0, in right context of prevents cues:0,
in left context of treats cues:0, in right context of treats cues:0,
in left context of treats symptoms cues:0, in right context of treats symptoms cues:0,
in left context of contraindicated cues:0, in right context of contraindicated cues:0,
in left context of affliction adj cues:0, in right context of affliction adj cues:0,
in left context of indication cues:0, in right context of indication cues:0,
in left context of details cues:0, in right context of details cues:0.
Table A1: Hand-built features of the word bacteria in a Drug–Disease Relations dataset example. These features
describe the word’s adjacent words, adjacent POS tags, and semantic environment (section 2). The detailed
meanings of hand-built features in the table are described as below: Adjacent words features: “word(±1/2/3/4)”
feature the word and adjacent words within a window size of 9. Adjacent POS tags features: “tag(±1/2/3/4)” fea-
ture the tags of word and its adjacent words within a window size of 9. Semantic environment features: “bias” is
always 1 for all words; “is upper” specifies whether the word is upper case or lower case; “is title” features whether
the word is in the title or not; “is punctuation” specifies whether the token is actually a word or a punctuation.
“in left/right context of negative/prevents/treats( symptoms)/contraindicted/afflicition adj/indication/details cues”
feature whether the word is in the left or right context (of specific window size like 4) of cue-words from specific
lexicons. Features related to 8 lexicons are shown in this example. Concrete examples: not, none and no are three
cue-words of lexicon “negative cues”, prevent and avoid are two cue-words of lexicon “prevents cues”, treat,
solve and alleviate are three cue-words of lexicon “treats cues” etc. Different semantic environments are defined
in the five datasets by carefully defining the lexicons/cue-words from various sources which possibly contain
corresponding domain knowledge, as discussed in section 2 and section 3.
Diagnosis Prescription Penn Adverse Drug Chemical–Disease Drug–Disease
Statistics Detection Reasons Reactions (ADR) Relations (CDR) Relations
# texts 6042 5179 – – –
# training texts – – 749 1000 9494
# test texts – – 272 500 500
mean text length 17 19 19 227 30
max text length 374 258 40 623 542
# labels 4 4 5 3 5
Table A2: Statistics for our five datasets. The sample size varies from around 1,000 to 10,000. The mean text
length (measured as the number of words) varies from 17 (short sentences) to 227 (full paragraphs). The number
of labels varies from 3 to 5. ADR, CDR, and Drug–Disease Relations are already partitioned into training and test
sets, while Diagnosis Detection and Prescription Reasons do not have predefined splits.
Diagnosis Prescription Penn Adverse Drug Chemical–Disease Drug–Disease
Models Hyperparams Detection Reasons Reactions (ADR) Relations (CDR) Relations
rand-LSTM-CRF
η 1e-4 1e-4 1e-4 1e-4 1e-4
epochtune 3 3 513 10 13
epochtrain 34 40 3076 164 130Rc1 { 0, 3e-5, 1e-4, 3e-4, 1e-3 }
Rc2 { 0, 3e-4, 1e-3, 3e-3, 1e-2 }
HB-CRF
η 1e-2 1e-2 3e-2 1e-2 1e-4
epochtune 1 1 10 2 3
epochtrain 3 4 82 10 35Rc1 { 0, 3e-6, 1e-5, 3e-5, 1e-4 }
Rc2 { 0, 3e-5, 1e-4, 3e-4, 1e-3 }
ELMo-LSTM-CRF
η 1e-3 1e-3 1e-4 1e-3 5e-6
epochtune 1 1 10 2 3
epochtrain 3 4 82 10 35Rc1 { 0, 3e-5, 1e-4, 3e-4, 1e-3 }
Rc2 { 0, 3e-4, 1e-3, 3e-3, 1e-2 }
ELMo-LSTM-CRF-HB
η 1e-3 1e-3 1e-4 1e-3 1e-5
epochtune 1 1 10 2 3
epochtrain 3 4 82 5 35Rc1 { 0, 3e-7, 1e-6, 3e-6, 1e-5 }
Rc2 { 0, 3e-6, 1e-5, 3e-5, 1e-4 }
Table A3: Hyperparameters for our experiments. The step size η is first manually tuned within the training set
when the `1 and `2 regularizers are set to be zeros. The coefficients c1 and c2 of the `1 and `2 regularizers are
determined via random search (for 10 settings) from ranges Rc1 and Rc2 during tuning (Bergstra and Bengio,
2012). Epochs of tuning epochtune are set to 1∼3 to reduce tuning time for most datasets (which consumes most
of the time for the experiments). It is set to 10 for ADR since that dataset is so small that it is hard to see clear
trends after just one epoch. Epochs of training epochtrain are set to be large enough until the training converges.
The ‘rand-LSTM-CRF’ model requires many more epochs for tuning and training because of the updates to the
randomly initialized embeddings.
FDA Drug Labels
Crowdsourcing
Maximization
Expectation
Init
End
convergence
Expert annotation
Drug-Disease 
Relations Dataset
Figure A1: Procedure for building the Drug–Disease Relations dataset. 10,000 raw sentences from the FDA Drug
Labels corpus were annotated by participants from 72 countries on the Figure Eight platform (crowdsourcing).
Expectation Maximization was used to infer labels for all the annotated sentences used for training. A team of
experts independently labeled different examples for testing. The resulting dataset consists of 9,500 crowdsourced
examples and 500 expert-annotated examples.
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Figure A2: Text-length experiment for the Penn Adverse Drug Reactions (ADR) dataset. Since ADR uses the IOB
tag format, in order to calculate per-token F1 scores, we collapse test-set labels starting with ‘B-’ and ‘I-’ into the
same labels. The ELMo-LSTM-CRF always performs better than the HB-CRF, while the combined model takes
advantage of both models and always outperforms both base models. Figure 2 provides comparable plots for the
other four datasets.
Penn Adverse Drug Reactions (ADR)
Label Support F1 score Improvement
OTHER 5023 98.0 0.3%
ADR 283 57.1 17.7%
INDICATION 29 35.9 178.3%
Table A4: Relative F1 score improvements of different labels in the Penn Adverse Drug Reactions (ADR) dataset.
To bring the IOB tag format of this dataset in line with our others, ADR merges B-ADR and I-ADR, and INDI-
CATION merges B-INDICATION and I-INDICATION. Consistent with table 3, the combined model gains most in
the smallest categories.
